Market Closed -
Bombay S.E.
03:00:39 2024-05-18 EDT
|
5-day change
|
1st Jan Change
|
85.92
INR
|
+2.37%
|
|
+2.62%
|
-14.41%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
126.1
|
549.5
|
389.9
|
1,287
|
3,308
|
6,164
|
Enterprise Value (EV)
1 |
1,333
|
629
|
455.8
|
1,343
|
3,362
|
6,202
|
P/E ratio
|
-0.28
x
|
-1.08
x
|
-1.65
x
|
-2.22
x
|
-9.73
x
|
6.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.09
x
|
0.31
x
|
0.25
x
|
1.95
x
|
1.88
x
|
1.2
x
|
EV / Revenue
|
1
x
|
0.36
x
|
0.29
x
|
2.04
x
|
1.91
x
|
1.21
x
|
EV / EBITDA
|
-3.42
x
|
-1.94
x
|
-2.41
x
|
-2.47
x
|
-10.4
x
|
6.34
x
|
EV / FCF
|
9.28
x
|
3.12
x
|
4.13
x
|
6.17
x
|
-2
x
|
-5.95
x
|
FCF Yield
|
10.8%
|
32.1%
|
24.2%
|
16.2%
|
-50%
|
-16.8%
|
Price to Book
|
-0.05
x
|
-0.32
x
|
-0.2
x
|
-0.5
x
|
-1.14
x
|
63.7
x
|
Nbr of stocks (in thousands)
|
14,796
|
121,836
|
121,836
|
121,836
|
121,836
|
121,836
|
Reference price
2 |
8.520
|
4.510
|
3.200
|
10.56
|
27.15
|
50.59
|
Announcement Date
|
18-07-06
|
19-07-07
|
20-08-25
|
21-08-03
|
22-08-26
|
23-08-31
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,336
|
1,748
|
1,588
|
659.4
|
1,759
|
5,129
|
EBITDA
1 |
-390.3
|
-324.2
|
-189
|
-543.7
|
-322
|
977.9
|
EBIT
1 |
-413.6
|
-358.9
|
-222.7
|
-576
|
-352.4
|
941.1
|
Operating Margin
|
-30.96%
|
-20.53%
|
-14.03%
|
-87.35%
|
-20.03%
|
18.35%
|
Earnings before Tax (EBT)
1 |
-441.7
|
-379.1
|
-236.3
|
-580
|
-339.7
|
787.6
|
Net income
1 |
-447.5
|
-379.1
|
-236.3
|
-580
|
-339.7
|
1,012
|
Net margin
|
-33.5%
|
-21.68%
|
-14.88%
|
-87.96%
|
-19.31%
|
19.73%
|
EPS
2 |
-30.24
|
-4.180
|
-1.940
|
-4.761
|
-2.790
|
8.300
|
Free Cash Flow
1 |
143.7
|
201.9
|
110.3
|
217.5
|
-1,681
|
-1,042
|
FCF margin
|
10.75%
|
11.55%
|
6.95%
|
32.98%
|
-95.54%
|
-20.32%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18-07-06
|
19-07-07
|
20-08-25
|
21-08-03
|
22-08-26
|
23-08-31
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,207
|
79.5
|
66
|
56.4
|
54.2
|
38.1
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-3.093
x
|
-0.2453
x
|
-0.3491
x
|
-0.1037
x
|
-0.1684
x
|
0.0389
x
|
Free Cash Flow
1 |
144
|
202
|
110
|
217
|
-1,681
|
-1,042
|
ROE (net income / shareholders' equity)
|
20.2%
|
18.1%
|
12.7%
|
25.6%
|
12.5%
|
-72.2%
|
ROA (Net income/ Total Assets)
|
-22%
|
-18.1%
|
-10.9%
|
-29.9%
|
-17.5%
|
17.2%
|
Assets
1 |
2,035
|
2,093
|
2,158
|
1,938
|
1,943
|
5,869
|
Book Value Per Share
2 |
-165.0
|
-14.30
|
-16.20
|
-21.00
|
-23.80
|
0.7900
|
Cash Flow per Share
2 |
0.0800
|
0
|
0.1100
|
0.0200
|
0.0700
|
0
|
Capex
1 |
68.5
|
6.89
|
1.84
|
27.4
|
78.2
|
104
|
Capex / Sales
|
5.13%
|
0.39%
|
0.12%
|
4.16%
|
4.45%
|
2.03%
|
Announcement Date
|
18-07-06
|
19-07-07
|
20-08-25
|
21-08-03
|
22-08-26
|
23-08-31
|
|
1st Jan change
|
Capi.
|
---|
| -14.41% | 123M | | -1.30% | 75B | | +0.19% | 47.43B | | +3.87% | 33.41B | | +11.03% | 18.24B | | +11.76% | 11.8B | | -16.29% | 10.93B | | +1.70% | 10.97B | | -0.10% | 9.26B | | -8.12% | 8.11B |
Diversified Chemicals
|